GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoString Technologies Inc (FRA:0F1) » Definitions » Forward PE Ratio

NanoString Technologies (FRA:0F1) Forward PE Ratio : 0.00 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is NanoString Technologies Forward PE Ratio?

NanoString Technologies's Forward PE Ratio for today is 0.00.

NanoString Technologies's PE Ratio without NRI for today is 0.00.

NanoString Technologies's PE Ratio for today is 0.00.


NanoString Technologies Forward PE Ratio Historical Data

The historical data trend for NanoString Technologies's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoString Technologies Forward PE Ratio Chart

NanoString Technologies Annual Data
Trend
Forward PE Ratio

NanoString Technologies Quarterly Data
Forward PE Ratio

Competitive Comparison of NanoString Technologies's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, NanoString Technologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoString Technologies's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NanoString Technologies's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where NanoString Technologies's Forward PE Ratio falls into.



NanoString Technologies Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


NanoString Technologies  (FRA:0F1) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


NanoString Technologies Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of NanoString Technologies's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoString Technologies (FRA:0F1) Business Description

Traded in Other Exchanges
Address
530 Fairview Avenue North, Seattle, WA, USA, 98109
NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

NanoString Technologies (FRA:0F1) Headlines

No Headlines